Vanguard Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $35.2M | Buy |
|
|||||
|
2025
Q2 | $56.9M | Sell |
|
|||||
|
2025
Q1 | $43.9M | Buy |
|
|||||
|
2024
Q4 | $36.6M | Buy |
|
|||||
|
2024
Q3 | $48.6M | Buy |
|
|||||
|
2024
Q2 | $27.7M | Buy |
|
|||||
|
2024
Q1 | $29.5M | Buy |
|
|||||
|
2023
Q4 | $11.5M | Sell |
|
|||||
|
2023
Q3 | $8.02M | Buy |
|
|||||
|
2023
Q2 | $12.4M | Buy |
|
|||||
|
2023
Q1 | $11.1M | Buy |
|
|||||
|
2022
Q4 | $14.4M | Buy |
|
|||||
|
2022
Q3 | $5.74M | Buy |
|
|||||
|
2022
Q2 | $4.48M | Buy |
|
|||||
|
2022
Q1 | $2.89M | Sell |
|
|||||
|
2021
Q4 | $8.73M | Sell |
|
|||||
|
2021
Q3 | $16.7M | Buy |
|
|||||
|
2021
Q2 | $30.8M | Sell |
|
|||||
|
2021
Q1 | $47.4M | Buy |
|
|||||
|
2020
Q4 | $2.32M | Buy |
|